ALB and diabetic kidney disease: In a recent metabolomics study by Kikuchi et al. [93], the gut microbiome-derived uremic toxin metabolite phenyl sulfate was shown to function as a marker of DKD progression and was correlated with the urine Alb/Cr ratio in a cohort of 363 diabetic patients following 2 years of follow-up.